Cargando…

Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma

Glioblastoma multiforme (GBM) is the most aggressive malignant primary central nervous system tumor. Although surgery, radiotherapy, and chemotherapy treatments are available, the 5-year survival rate of GBM is only 5.8%. Therefore, it is imperative to find novel biomarker for the prognosis and trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xiaopeng, Pan, Sian, Li, Rui, Chen, Zebo, Xie, Xingyun, Han, Deqing, Lv, Shengqing, Huang, Yongkai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714878/ https://www.ncbi.nlm.nih.gov/pubmed/34976783 http://dx.doi.org/10.3389/fonc.2021.667884

Ejemplares similares

Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma
por: Zhu, Xiaopeng, et al.
Publicado: (2021)

Serum Inflammatory Biomarkers Contribute to the Prognosis Prediction in High-Grade Glioma
por: Chen, Xiao-Yong, et al.
Publicado: (2022)

A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis
por: Wang, Lin-jian, et al.
Publicado: (2022)

Abnormal Topological Network in Parkinson’s Disease With Impulse Control Disorders: A Resting-State Functional Magnetic Resonance Imaging Study
por: Zhu, Xiaopeng, et al.
Publicado: (2021)

A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
por: Peng, Xiaojiang, et al.
Publicado: (2023)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma
por: Yang, Zhihao, et al.
Publicado: (2022)

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
por: Xiao, Youchao, et al.
Publicado: (2020)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients
por: Li, Hainan, et al.
Publicado: (2021)

A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma
por: Zheng, Yinfei, et al.
Publicado: (2022)

Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas
por: Zhu, Huaxin, et al.
Publicado: (2022)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Overall Survival Prediction for Gliomas Using a Novel Compound Approach
por: Huang, He, et al.
Publicado: (2021)

A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma
por: Zhang, Yu, et al.
Publicado: (2021)

A Focal Adhesion-Related Gene Signature Predicts Prognosis in Glioma and Correlates With Radiation Response and Immune Microenvironment
por: Li, Haonan, et al.
Publicado: (2021)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

Analysis of the Factors Affecting the Prognosis of Glioma Patients
por: Wang, Jiancun, et al.
Publicado: (2019)

A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients
por: Wu, Wei, et al.
Publicado: (2022)

Relative T2-FLAIR signal intensity surrounding residual cavity is associated with survival prognosis in patients with lower-grade gliomas
por: Yuan, Tao, et al.
Publicado: (2022)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma
por: Gao, Dandan, et al.
Publicado: (2023)

ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in Gliomas
por: Li, Shuyu, et al.
Publicado: (2022)

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
por: Yang, Shu, et al.
Publicado: (2022)

An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas
por: Xu, Yang, et al.
Publicado: (2020)

Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas
por: Liu, Peidong, et al.
Publicado: (2022)

Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma
por: Wang, Peng, et al.
Publicado: (2020)

Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
por: Lin, Wanzun, et al.
Publicado: (2020)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Latest updates on cellular and molecular biomarkers of gliomas
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Pre-diagnostic blood biomarkers for adult glioma
por: Andrews, Lily J., et al.
Publicado: (2023)

CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas
por: Liu, Liling, et al.
Publicado: (2021)

Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma
por: Lin, Xuelei, et al.
Publicado: (2022)

H2B gene family: A prognostic biomarker and correlates with immune infiltration in glioma
por: Jia, Jingnan, et al.
Publicado: (2022)

A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma
por: Xia, Pengfei, et al.
Publicado: (2022)

A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas
por: Gao, Feng, et al.
Publicado: (2021)

Identification of prognosis-related gene features in low-grade glioma based on ssGSEA
por: He, Yuanzhi, et al.
Publicado: (2022)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

CASP4 can be a diagnostic biomarker and correlated with immune infiltrates in gliomas
por: Tian, Guopeng, et al.
Publicado: (2023)

Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas via Large-Scale Analysis
por: Huang, Xiaoming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8g96cqe0ae8h0a2cs4ull7s4un